Globus Medical (GMED) Tops Q1 EPS by 12c, Offers Guidance

Globus Medical (NYSE: GMED) reported Q1 EPS of $0.49, $0.12 better than the analyst estimate of $0.37. Revenue for the quarter came in at $227.3 million versus the consensus estimate of $198.39 million.

GUIDANCE:

Globus Medical sees FY2021 EPS of $1.83-$1.89, versus the consensus of $1.84. Globus Medical sees FY2021 revenue of $925 million, versus the consensus of $881.6 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• New leader board: Citi refreshes AI compute semiconductor picks
• SilverCape cuts acquisition bid for PetMed Express to $3 per share
• Morgan Stanley continues to recommend exposure to the broadening theme